How Dismantling DEI Efforts Could Make Clinical Trials Less Representative

Abstract

This Medical News article discusses how the Trump administration’s dismantling of diversity, equity, and inclusion could halt progress made in enrolling clinical trial participants who represent the patient populations likely to use the treatments being tested.